Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
24.92
-0.03 (-0.12%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Denali Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $29 | Buy | Maintains | $29 | +16.37% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $42 | Buy | Maintains | $42 | +68.54% | Aug 7, 2026 |
| UBS | UBS | Buy Reiterates $25 → $34 | Buy | Reiterates | $25 → $34 | +36.44% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $36 → $40 | Buy | Reiterates | $36 → $40 | +60.51% | Aug 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $41 | Buy | Reiterates | $41 | +64.53% | Aug 7, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $31 → $34 | Buy | Maintains | $31 → $34 | +36.44% | Aug 7, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +56.50% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $31 | Buy | Reiterates | $31 | +24.40% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.